Your browser doesn't support javascript.
Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice.
da Silva Santos, Yasmin; Gamon, Thais Helena Martins; de Azevedo, Marcela Santiago Pacheco; Telezynski, Bruna Larotonda; de Souza, Edmarcia Elisa; de Oliveira, Danielle Bruna Leal; Dombrowski, Jamille Gregório; Rosa-Fernandes, Livia; Palmisano, Giuseppe; de Moura Carvalho, Leonardo José; Luvizotto, Maria Cecília Rui; Wrenger, Carsten; Covas, Dimas Tadeu; Curi, Rui; Marinho, Claudio Romero Farias; Durigon, Edison Luiz; Epiphanio, Sabrina.
  • da Silva Santos Y; Laboratory of Cellular and Molecular Immunopathology of Malaria, Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
  • Gamon THM; Laboratory of Malaria Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil.
  • de Azevedo MSP; Laboratory of Clinical and Molecular Virology, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
  • Telezynski BL; Laboratory of Clinical and Molecular Virology, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
  • de Souza EE; Laboratory of Experimental Immunoparasitology, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
  • de Oliveira DBL; Laboratory of Clinical and Molecular Virology, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
  • Dombrowski JG; Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
  • Rosa-Fernandes L; Laboratory of Clinical and Molecular Virology, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
  • Palmisano G; Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
  • de Moura Carvalho LJ; Laboratory of Experimental Immunoparasitology, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
  • Luvizotto MCR; Laboratory of Clinical and Molecular Virology, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
  • Wrenger C; GlycoProteomics Laboratory, Department of Parasitology, ICB, University of São Paulo, São Paulo 05508-000, Brazil.
  • Covas DT; GlycoProteomics Laboratory, Department of Parasitology, ICB, University of São Paulo, São Paulo 05508-000, Brazil.
  • Curi R; School of Natural Sciences, Macquarie University, Sydney 2109, Australia.
  • Marinho CRF; Laboratory of Malaria Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil.
  • Durigon EL; School of Veterinary Medicine of Araçatuba, São Paulo State University, São Paulo 16050-680, Brazil.
  • Epiphanio S; Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
Viruses ; 15(4)2023 04 19.
Artigo em Inglês | MEDLINE | ID: covidwho-2293805
ABSTRACT
Since December 2019, the world has been experiencing the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and we now face the emergence of several variants. We aimed to assess the differences between the wild-type (Wt) (Wuhan) strain and the P.1 (Gamma) and Delta variants using infected K18-hACE2 mice. The clinical manifestations, behavior, virus load, pulmonary capacity, and histopathological alterations were analyzed. The P.1-infected mice showed weight loss and more severe clinical manifestations of COVID-19 than the Wt and Delta-infected mice. The respiratory capacity was reduced in the P.1-infected mice compared to the other groups. Pulmonary histological findings demonstrated that a more aggressive disease was generated by the P.1 and Delta variants compared to the Wt strain of the virus. The quantification of the SARS-CoV-2 viral copies varied greatly among the infected mice although it was higher in P.1-infected mice on the day of death. Our data revealed that K18-hACE2 mice infected with the P.1 variant develop a more severe infectious disease than those infected with the other variants, despite the significant heterogeneity among the mice.
Assuntos
Palavras-chave

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Estudo experimental / Estudo prognóstico / Ensaios controlados aleatorizados Tópicos: Variantes Limite: Animais / Humanos Idioma: Inglês Ano de publicação: 2023 Tipo de documento: Artigo País de afiliação: V15040999

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Estudo experimental / Estudo prognóstico / Ensaios controlados aleatorizados Tópicos: Variantes Limite: Animais / Humanos Idioma: Inglês Ano de publicação: 2023 Tipo de documento: Artigo País de afiliação: V15040999